Kidney Cancer, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology
Robert J. Motzer(St. Jude Children's Research Hospital), Eric Jonasch, Neeraj Agarwal(St. Jude Children's Research Hospital), Sam B. Bhayani, William P. Bro, Sam S. Chang, Toni K. Choueiri(St. Jude Children's Research Hospital), Brian A. Costello(St. Jude Children's Research Hospital), Ithaar Derweesh, Mayer Fishman(St. Jude Children's Research Hospital), Thomas H. Gallagher, John L. Gore, Steven Hancock, Michael R. Harrison(St. Jude Children's Research Hospital), Won Kim(St. Jude Children's Research Hospital), Christos E. Kyriakopoulos, Chad A. LaGrange, Elaine T. Lam(St. Jude Children's Research Hospital), Clayton Lau, M. Dror Michaelson, Thomas Olencki, Phillip M. Pierorazio, Elizabeth R. Plimack(St. Jude Children's Research Hospital), Bruce G. Redman(St. Jude Children's Research Hospital), Brian Shuch, Brad Somer, Guru Sonpavde, Jeffrey A. Sosman(Moffitt Cancer Center), Mary A. Dwyer, Rashmi Kumar
Cited by 579Open Access
Abstract
The NCCN Guidelines for Kidney Cancer provide multidisciplinary recommendations for the clinical management of patients with clear cell and non-clear cell renal carcinoma. These guidelines are developed by a multidisciplinary panel of leading experts from NCCN Member Institutions consisting of medical oncologists, hematologists and hematologic oncologists, radiation oncologists, urologists, and pathologists. The NCCN Guidelines are in continuous evolution and are updated annually or sometimes more often, if new high-quality clinical data become available in the interim.
Related Papers
No related papers found
Powered by citation graph analysis